Skip to main content

Advertisement

Table 1 Anti-NMDA-R follow-up of the titration in CSF and in serum (qualitative and quantitative)

From: Extensive myelitis associated with anti-NMDA receptor antibodies

Date Jun 23rd Jul 2nd Jul 10th Jul 11th Jul 14th Jul 16th Jul 17th Jul 23rd Jul 30th Aug 6th Aug 13th Oct 17th
CSF + (1/10) + (low) NA NA NA NA - NA NA NA NA -
Anti-NMDA-R in serum NA NA + (1/10) + (1/10) - + (low) - - + (low) NA + (1/10) -
Methylprednisolone (1 g/day IV) 3 days   5 days          
PLEX    Yes Yes Yes Yes Yes      
Rituximab (375 mg/m2/week during 4 weeks)         Yes Yes Yes Yes  
  1. Jun, June; Jul, July; Aug, August; Oct, October; CSF, cerebrospinal fluid; NA, not available; PLEX, plasma exchange; 5 PLEX were performed followed by infusions of rituximab (375 mg/m2/week during 4 weeks).